Pharmaceutical Research and Manufacturers of America

Recent papers from Pharmaceutical Research and Manufacturers of America

1. Regulation of the circulation of veterinary medicinal substances in the Eurasian Economic Union based on uniform principles: transition challengesLegal regulation in veterinary medicine · 2026
2. Recommendations for generating real-world evidence with regulatory-grade relevance and reliabilityInternational Journal of Clinical Oncology · 2026
3. The Indiana fingerprint comparison databaseForensic Science International Synergy · 2026
4. Strengthening Value Assessment and Health Economics and Outcomes Research Proposals Through Patient Engagement: Guidelines for ResearchersPatient · 2026
5. High-Throughput Screening Identifies Covalent Inhibitors with Unique Chemistry and Binding Modes for SARS-CoV-2 Main ProteaseJACS Au · 2026
6. Symposium Report: Stakeholders' Perspectives on Phase 1 Trials in Japanese Prior to Multi‐Regional Clinical Trials and Future PathwaysClinical Pharmacology & Therapeutics · 2026
7. Digital Transformation of Medicines Regulation in Africa—Perspectives from a Stakeholder ConveningClinical Pharmacology & Therapeutics · 2026
8. Challenges in the nonclinical safety evaluation of biotechnology-derived pharmaceuticals and perspectives for revision of the ICH S6 guideline based on analysis of approved products in JapanTranslational and Regulatory Sciences · 2026
9. The Current State of Regulatory Post-Marketing Studies in Japan: A Questionnaire Survey on Good Post-Marketing Study PracticeJapanese Journal of Pharmacoepidemiology/Yakuzai ekigaku · 2026
10. An analysis of advanced therapy medicinal products regulatory landscape in ICH member countries: opportunities and challengesCell and Gene Therapy Insights · 2026
11. Impact of the FDA roadmap and perspectives for regulatory use of new approach methodologies in Japanese pharmaceutical companiesNAM journal. · 2026
12. Nanotransethosomal co-drug delivery system of diclofenac sodium and rosmarinic acid against rheumatoid arthritis: design, formulation, characterisation and pre-clinical studiesJournal of drug targeting · 2025
13. De Novo Synthesis of Multisubstituted Pyrrolidines Based on a Programmed Radical [2 + 2 + 1] Annulation Strategy Using Sulfide-Based Electron Donor-Acceptor Catalysis2025
14. Crystallizing the Uncrystallizable: Insights from Extensive Screening of PROTACsJournal of the American Chemical Society · 2025
15. ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global ConvergenceClinical Pharmacology & Therapeutics · 2025
16. Design and Bottom-up Production of an Aerosolizable Cannabidiol NanosuspensionMolecular Pharmaceutics · 2024
17. Affordability and adherence gains for Medicare Part D low-income subsidy recipients when low-income subsidy benefits expanded in 2024Journal of Managed Care & Specialty Pharmacy · 2024
18. Cost-effectiveness of medication therapy management among Medicare population and across racial/ethnic groupsMedicine · 2024
19. Medicare Part D low-income subsidies expanded in January 2024, but more needs to be done to ensure that eligible beneficiaries enrollJournal of Managed Care & Specialty Pharmacy · 2024
20. Evolution of phage display libraries for therapeutic antibody discoverymAbs · 2023